Chong Lu

Targeting CD96 overcomes PD-1 blockade resistance by enhancing CD8+ TIL function in cervical cancer

Yumeng Wang, Congwen Wang, Junjun Qiu et al. · Journal for ImmunoTherapy of Cancer · 2022 · 59 citations · Full text

Anhydroicaritin, a SREBPs inhibitor, inhibits RANKL-induced osteoclastic differentiation and improves diabetic osteoporosis in STZ-induced mice

Zu‐Guo Zheng, Xin Zhang, Yaping Zhou et al. · European Journal of Pharmacology · 2017 · 42 citations

Diabetic Osteoporosis, Sclerostin, Bone Morphogenic Protein +10

Association of LDL-C/HDL-C Ratio With Stroke Outcomes Within 1 Year After Onset: A Hospital-Based Follow-Up Study

Li Liu, Ping Yin, Chong Lu et al. · Frontiers in Neurology · 2020 · 40 citations · Full text

Cerebrovascular Disease, Hyperlipidemia, Stroke Patients +20

Anhydroicaritin improves diet-induced obesity and hyperlipidemia and alleviates insulin resistance by suppressing SREBPs activation

Zu‐Guo Zheng, Yaping Zhou, Xin Zhang et al. · Biochemical Pharmacology · 2016 · 37 citations

Insulin Resistance, Nutrition, Obesity +13

Effects of Celastrol on growth inhibition of U937 leukemia cells through the regulation of the Notch1/NF-kappa B signaling pathway in vitro

Xiaonan Wang, Qing Wu, Yang Xu et al. · Chinese Journal of Cancer · 2010 · 33 citations